---
title: Ampullary composite gangliocytoma/neuroma and neuroendocrine tumor management
date: '2025-01-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39745186/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250102170931&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Ampullary composite gangliocytoma/neuroma and neuroendocrine tumor (CoGNET),
  previously called ampullary gangliocytic paragangliomas (GP) are a rare entity,
  with only few reported cases in the literature. This is a multicentric retrospective
  cohort of patients treated with endoscopy or surgery for ampullary CoGNET. A literature
  review of ampullary CoGNET was also performed. Fifteen patients were included, mostly
  female (n=10) with a median age of 50 y.o. Patients were asymptomatic in 7 ...
disable_comments: true
---
Ampullary composite gangliocytoma/neuroma and neuroendocrine tumor (CoGNET), previously called ampullary gangliocytic paragangliomas (GP) are a rare entity, with only few reported cases in the literature. This is a multicentric retrospective cohort of patients treated with endoscopy or surgery for ampullary CoGNET. A literature review of ampullary CoGNET was also performed. Fifteen patients were included, mostly female (n=10) with a median age of 50 y.o. Patients were asymptomatic in 7 ...